Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lyme Disease Vaccine (VaxThera)
- Development stage
- Preclinical
- Lead developer
- VaxThera
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
01
Overview
The Lyme Disease Vaccine (VaxThera) is a viral-vector based vaccine currently in preclinical development by the Colombian biotechnology company VaxThera. The vaccine is designed to induce protective immunity against *Borrelia* species, the bacterial pathogens responsible for Lyme disease (Enfermedad de Lyme). According to company pipeline information, this specific program utilizes a viral vector platform and is categorized within VaxThera's veterinary vaccine portfolio. The development aims to provide a prophylactic solution to prevent the transmission and clinical manifestation of Lyme disease in animal populations.
- Other names
- Enfermedad de Lyme VaccineVaxThera Lyme disease vaccine
02
Targets
OspA (Outer surface protein A)
Beyond the preview
Go deeper on Lyme Disease Vaccine (VaxThera).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lyme Disease Vaccine (VaxThera).